1. Home
  2. CHCI vs OVID Comparison

CHCI vs OVID Comparison

Compare CHCI & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CHCI

Comstock Holding Companies Inc.

HOLD

Current Price

$11.74

Market Cap

104.4M

Sector

Real Estate

ML Signal

HOLD

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$1.76

Market Cap

117.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHCI
OVID
Founded
1985
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.4M
117.5M
IPO Year
2004
2017

Fundamental Metrics

Financial Performance
Metric
CHCI
OVID
Price
$11.74
$1.76
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$3.50
AVG Volume (30 Days)
30.1K
1.5M
Earning Date
11-13-2025
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
125.40
N/A
EPS
1.33
N/A
Revenue
$55,836,000.00
$6,610,000.00
Revenue This Year
N/A
$1,077.56
Revenue Next Year
N/A
N/A
P/E Ratio
$8.44
N/A
Revenue Growth
22.98
945.89
52 Week Low
$6.31
$0.24
52 Week High
$18.99
$2.01

Technical Indicators

Market Signals
Indicator
CHCI
OVID
Relative Strength Index (RSI) 56.30 57.19
Support Level $10.56 $1.48
Resistance Level $11.70 $1.65
Average True Range (ATR) 0.60 0.11
MACD 0.10 -0.01
Stochastic Oscillator 100.00 71.79

Price Performance

Historical Comparison
CHCI
OVID

About CHCI Comstock Holding Companies Inc.

Comstock Holding Co Inc is a developer and manager of mixed-use and transit-oriented properties with operations that are majorly focused on the Washington, D.C. metropolitan area. It provides a range of services such as asset management, property management, development and construction management, and other real estate-related services to its asset-owning clients, composed predominantly of institutional real estate investors, high net worth family offices, financial institutions, and governmental bodies seeking to enhance their surrounding communities by developing real estate through public-private partnerships.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: